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Abstract 
The temperature-sensitive malonyl CoA-ACP transacylase found in the Escherichia co/i strain LA2-89, carrying the fabD89 allele, was shown to 
result from the presence of an amber mutation in thefabD gene, at codon position 257, in combination with the supE44 genotype of this strain. The 
truncated form of the protein produced as the result of the amber mutation was demonstrated to be enzymatically inactive, whereas amber suppression 
rendered the resulting enzyme temperature labile. Site-directed mutagenesis of codon 257 revealed a requirement for an aromatic amino acid at this 
position in the polypeptide chain, to assure temperature stability of the enzyme. 
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1. Introduction 
De novo synthesis of fatty acids in Escherichia coli is 
catalysed by a type II fatty acid synthetase (FAS II), a 
similar system to that found in plants. Each of the eight 
reactions involved in this system is carried out by sepa- 
rate, and structurally independent proteins. This is in 
contrast to the so-called type I FAS, as found in yeasts 
and vertebrates, in which the individual reactions are 
catalysed by domains of a multi-enzyme complex con- 
sisting of one or two polypeptide chains [I]. Elucidation 
of the lipid biosynthetic pathway of E. coli has made an 
important contribution to our understanding of the syn- 
thesis and function of lipids in general. The existence of 
E. coli fatty acid biosynthesis vab) mutants has greatly 
facilitated this work. These mutants have not only al- 
lowed the detailed dissection of the individual enzymic 
steps of the pathway, but also provide a powerful tool 
to study the complex structure-function relationships 
between the fatty acid synthetase components that are 
essential for the function of this multi-enzyme complex. 
In this context, thermolabile mutant proteins are of par- 
ticular interest since they often involve amino acid 
changes which affect the correct folding of the protein 
[2,3], and may also affect the interaction with other com- 
ponents of the multi-enzyme complex. 
Recently, we have cloned the E. coli fabD gene [4], 
encoding malonyl CoA-ACP transacylase (MCAT), by 
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complementation of a temperature-sensitive fatty acid 
biosynthesis mutant (LA2-89) [5]. MCAT catalyses the 
transacylation of malonate from coenzyme A to the acyl 
carrier protein (ACP) and thus provides the activated 
acetyl units required during the repeated condensation 
cycles of fatty acid synthesis. In this study we have analy- 
sed the complex nature of the mutations in the E. coli 
LA2-89 strain which are responsible for the temperature- 
labile MCAT activity and temperature-sensitive growth 
phenotype of this strain. In pursuit of the solution of 
MCAT’s three-dimensional structure, the E. coli MCAT 
was recently crystallized [6]; this could further our study 
of structure-function relationships of FAS II components. 
2. Materials and methods 
2.1. Protein extract preparation 
Protein extracts were prepared as described by Verwoert et al. [4], 
with minor modifications. After DNase treatment, enzyme assays or gel 
electrophoresis were performed on the total or the soluble fraction of 
the lysate. The latter was obtained by fractionation of the lysate into 
pellet and supematant by centrifugation in a microfuge. The pellet was 
resuspended by vigorous pipetting, again followed by centrifugation. 
The first and second supematant were pooled and constituted the 
soluble fraction. 
2.2. Enzyme and protein assays 
Protein and MCAT were routinely assayed as described in Verwoert 
et al. [4]. 
2.3. Cloning and nucleotide sequence analysis of the fabD89 gene 
In order to clone the mutant MCAT coding region, as a NcoI- 
Hind111 fragment, into vector pUCl9 [7], a PCR was performed on 
chromosomal DNA of E. coli strain LA289 (51. Primers used previ- 
ously to clone the wild-type E. coli MCAT gene [4] served to introduce 
the appropriate restriction sites. Using the restriction sites present in 
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the fabD89 gene (the same as can be found in the wild-type fabD gene, 
Fig. l), DNA fragments of the fabD89 coding region were subcloned 
in M13mp18 and M13mp19, and dideoxy sequencing employing an 
Applied Biosystems DNA Sequencer model 370A was performed as 
described by Verwoert et al. [4]. 
2.4. Construction of pIV6 mutant plasmids by site-directed mutagenesis 
The collection of mutant plasmids was obtained by oligonucleotide- 
directed mutaeenesis on DIVE 141 olasmid DNA. The modification 
involved two d%ferent PCR rout&, as shown in Fig. 1. In the first PCR 
(Fig. 1A) the Ml 3 Forward primer (FW) was used in combination with 
either primer I (5’ CGG’ITCAGCAGACGAAGTCTGTTG 3’), which 
changes the tryptophan (w) at codon position 257 of thefabD coding 
region into a glutamine (Q), or the mixed primer II (5’ CGGTTCAG- 
C/T/G-C/A/G-C/T/G-ACGAAGTCTGTTG 3’), which can introduce 
12 different amino acids at codon position 257. The following thermal 
cycle was used: denaturation at 94°C for 30 s; annealing at 55°C for 
60 s; and extension at 72°C for 90 s, repeated 30 times. The PCR 
product was a 400 bp fragment with the change of W-to-Q at the 
marked position (codon position 257 of the fabD coding region, Fig. 
1) or, when mixed primer II was used, a collection of 400 bp double- 
stranded (ds) DNA molecules encoding different amino acids at the 
marked position (Fig. 1) in both strands. In order to exchange the 
mutated pIV6 fragments with the wild-type pIV6 fragment, the se- 
quence of the pMIC1960 insert (a single stranded M13mp19 derivative, 
containing part of thefabD gene, Fig. 1) was modified by a second PCR 
(Fig. 1B). The Ml3 Reverse primer (Rev) was used in combination with 
the complementary strand of the 400 bp PCR products. The tem- 
plate:primer ratio was optimal at 1: 10, and the thermal 
cycle used was the same as in the first PCR. This PCR resulted in ds 
750 bp fragments with a PstI site located 5’ upstream of the mutated 
codon (Fig. 1). The 400 bp PCR products used as a primer in the second 
PCR were purified over a Qiagen column (Qiagen Inc., USA) to remove 
primer residues from the first PCR. The 750 bp PCR products were 
digested with PstI and Sac11 and ligated to pIV6 digestedwith the same 
restriction enzvmes. resulting in recombinant dasmids vIV6 (wz5’Q) 
and pIV6 (W”‘X). Since the zones obtained after the firstround ampG 
fication may contain a mixture of two distinct mutants, a second round 
of transformation was necessary. The nucleotide sequence of the region 
between the PstI and Sac11 sites of the resulting mutants was deter- 
mined for both strands by dideoxy-nucleotide sequence analysis as 
described above. 
2.5. Expression studies 
For over-expression i E. coli two type of vectors were used, pET1 l-d 
[8] and pIV6 [4]. In order to clone the wild-type and the mutant MCAT 
coding region into expression vector pETll-d [S] as a NcoI-BamHI 
fragment, a PCR was performed on chromosomal DNA of E. coli strain 
XLlBlue (recA_) (Stratagene) and LA2-89 [S]. The appropriate restric- 
tion sites were introduced, as described by Kater et al. [9], using the 
following primers: (1) 5’ CGTCTAGAATAAGGATTAAACC- 
ATGGCGC 3’, which introduces an _%%a1 nd an NcoI site at the 7 
starting ATG of the coding region [4], and (2) 5’ GGGGATCC- 
CGAAGCTTGCACCGG 3’, which changes the EcoRI site at the 
end of the coding region [4] into a BumHI site. Constructs derived from 
pET1 l-d were introduced into E. coli BL21 (DE3) [8], and pIV6 deriv- 
atives were introduced into E. coli XLlBlue (recA_) by transformation. 
Protein extracts were made as described in section 2.1. and used for 
MCAT assays, SDS-PAGE and Western immunoblotting as described 
previously [4]. 
2.6. Data analysis 
Kinetic parameters were determined by using Eadie-Hofstee plots, 
and all data were analysed by computer-assisted non-linear regression 
by using Enzlitter software. Standard errors were estimated by Enzfnter. 
3. Results and discussion 
3.1. Steady state kinetics 
As shown by Harder et al. [5], the E. coli strain LA289 
carrying thefabD89” allele is unable to grow at temper- 
atures higher than 35°C unless supplemented with long- 
chain fatty acids. The MCAT activity in this strain was 
found to be almost completely inactivated by pre-incuba- 
tion of the extract at 42°C under conditions which do 
not alter the activity of wild-type E. coli cells [4,5]. In 
addition to this temperature sensitivity, the MCAT activ- 
ity measured at the permissive temperature of 30°C was 
only 2.5% of that found in fabo’ E. coli strains [4,5]. 
Using malonyl-CoA as substrate, we determined the 
Michaelis constant (Kd of the wild-type and mutant 
MCAT protein in crude protein extracts of E. coli strain 
XLlBlue and LA2-89. Fitting the data in Eadie-Hofstee 
plots (not shown) gave identical values for the K, of 
wild-type and mutant MCAT (11 .O +_ 0.8 and 11.1 + 0.8 
yM, respectively). Consequently, the defect in the pro- 
tein does not affect its ability to bind to the substrate. 
The Vm, value for the mutant protein in crude extracts 
(6.8 + 0.2 nmol/min/mg total soluble protein) represents 
only 2-3% of that of wild-type MCAT in crude extracts 
(320.0 f 10.3 nmol/min/mg total soluble protein). Since 
the same relationship was found for the specific activity 
of mutant and wild-type extracts under standard assay 
conditions [4,5], and the kinetic properties of both en- 
zymes are the same, the reduction in the I’,,, value of the 
mutant protein must be due to a decrease in the amount 
of functionally active protein within the extract. 
3.2. The fabD89 allele contains an amber mutation at 
codon position 257 
An earlier study [4] demonstrated the presence of two 
MCAT-related polypeptides in E. coli strain LA2-89 
protein extracts (mol. wt. 32,000 and 27,000 Da), com- 
pared to a single one in wild-type strain extracts (32,000 
Da). To establish whether the two forms were the result 
of a mutation in the fabD89 gene, both strands were 
sequenced as described in section 2. A single G-to-A 
transition was found in the fabD89 gene as compared to 
the wild-type sequence at position 1301 [4]. This muta- 
tion alters the tryptophan codon (TGG, W) at codon 
position 257 into an amber codon (TAG, termination) 
(Fig. 1 and [4]). Premature termination of translation 
caused by this amber mutation explains the truncated 
form (27,000 Da) of the enzyme found in LA2-89. The 
additional synthesis of a protein with an apparently nor- 
mal size (32,000 Da) is most likely explained by the 
amber suppressor genotype (SupEM) of this strain. As 
demonstrated by Inokuchi et al. [lo], the duplicated and 
mutated tRNAg’” present in supE strains is capable of 
suppressing amber mutations by occasional insertion of 
a glutamine. Based upon these data, the full-length pro- 
tein found in this strain is expected to contain a glutam- 
ine (Q) instead of a tryptophan residue (W) at position 
257 of the amino acid sequence. To establish whether the 
truncated or the suppressed form of the protein is re- 
sponsible for the temperature-labile MCAT activity 
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found in LA2-89, we studied both forms separately by 
site directed mutagenesis and over-expression studies. 
3.3. The 27 kDa truncatedpolypeptide is enzymatically 
inactive 
To study the truncated MCAT protein in more detail, 
the fabD89 gene was over-expressed by the use of the 
E. coli expression vector pET1 l-d, as described in section 
2. The wild-type fabD gene was used as a control. Fig. 
2B shows a 12% SDS-PAGE gel of protein extracts of 
E. coli strain BL21 grown at 28”C, harboring these re- 
combinant pET1 l-d plasmids. Due to the non-suppres- 
sor genotype of BL21, over-expression of the fabD89 
allele only results in the synthesis of the truncated pol- 
ypeptide. Fractionation of the protein lysates into pellet 
and supernatant showed that, in contrast to the wild-type 
protein (Fig. 2B, lane l), the truncated protein was unde- 
tectable in the soluble fraction and all the protein was 
found in the low-speed pellet (Fig. 2B, lanes 4 and 5). The 
over-production of a protein up to a concentration level 
rare in nature can often be the reason for the formation 
of aggregates of ‘denatured’, insoluble polypeptide 
chains (also termed inclusion bodies) in E. coli [3]. In this 
case, however, the reason for aggregation must lie within 
the mutation itself, as inclusion bodies of the truncated 
form were also observed in the single copy situation. 
Immunoblot analysis of protein extracts prepared from 
LA2-89 carrying the fabD89 allele (Fig. 2A) demon- 
strated that the soluble fraction contained only the sup- 
pressed full-length protein (Fig. 2A, lane 2). Enzyme 
studies showed that MCAT levels of the total and soluble 
fraction of the LA2-89 protein extract, as well as that of 
the cells over-producing the truncated form, were identi- 
cal (data not shown). The MCAT enzymatic activity can 
therefore be totally attributed to the suppressed form of 
the protein, whereas the truncated form is catalytically 
inactive. The activity of the suppressed form explains 
why LA2-89 is still able to grow at 28”C, albeit slower 
as compared to a wild-type strain [5]. The inactivity of 
the truncated polypeptide explains the anomalous results 
found in earlier co-transduction experiments [l l] carried 
out to map the fabD locus, as introduction of the fabD89 
allele in a non-suppressor background is expected to be 
lethal. 
3.4. Site-directed mutagenesis of the tryptophan-257 of 
the wild-type fabD gene 
To investigate whether the incorporation of the glu- 
tamine (Q) by the SupE mutation of the LA2-89 strain 
rendered the suppressed protein heat labile, the nucleo- 
tide sequence of plasmid pIV6, carrying the wild-type 
fabD gene, was changed by site-directed mutagenesis, as 
described in section 2 (Fig. 1). A mutant protein was 
produced, pIV6(WZ5’+Q), in which Q replaced W-257. 
Since there is a clear relationship between temperature- 
sensitive mutations and protein structure and matura- 
tion [2,3], we have also used a degenerate oligonucleotide 
to introduce other amino acid codons at this position. 
B 
PCR-1 - 3’7j-$ 
s&n 
ds 400bp 
* 
5’ 
7 
3’ 
3’* 
Fw5 7( 
Sacll 
3’* 5’ 
Rev Fw 
Hindltl Pstl 
HindUI 
HindUI PstI SaclI 
ds 750bp 
Fig. 1. Construction of pIV6 mutant plasmids by site-directed mutagenesis. (A) First PCR on pIV6 plasmid DNA, with the Ml3 Forward primer 
(FW) and either primer I or II, resulting in PCR products of 400 bp with a mutation at the marked position (*). (B) Second PCR on pMIC1960 
ss DNA, with the Ml 3 Reverse primer (Rev) and the complementary strand of the 400 bp PCR product from the first PCR, resulting in PCR products 
of 750 bp with a mutation at the marked position (*). Subsequently, the PstI-Sac11 fragment carrying the mutation (*) was exchanged with the 
&-Sac11 fragment of pIV6, resulting in a collection of pIV6 derivatives. 
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- 32 - 
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1 2 3 4 5 
Fig. 2. (A) Western blot analysis of crude protein extracts prepared 
from E. coli LA2-89, grown at 28°C. Immunodetection of MCAT- 
related proteins was performed using anti-E. coli MCAT antibodies [4]. 
Lane 1, total protein fraction (approximately 10 ,ug protein); lane 2, 
soluble protein fraction. (B) 12% SDS-PAGE of approximately 10 pug 
of crude protein extracts of E. coli strain BL21, grown at 28°C harbor- 
ing different recombinant plasmids. Lane 1, pETSO (wild-type MCAT) 
with IPTG induction, soluble protein fraction; lane 2, pET60 (mutant 
MCAT) without IPTG, total protein fraction; lane 3, pET60 with 
IPTG, total protein fraction; lane 4, pET60 with IPTG, soluble protein 
fraction; lane 5, pET60 with IPTG, pellet fraction. Sizes are shown in 
kDa. The position of the truncated mutant MCAT protein is indicated 
by the arrow. 
The sequence of the oligonucleotide was chosen such 
that a collection of mutants would be obtained that 
would enable us to assess whether this site of the pol- 
ypeptide chain is crucial for correct folding or stability 
of the enzyme. The amino acid substitution mutants that 
were obtained (underlined) fall within 7 of the 8 amino 
acid groups with side chains of similar chemical proper- 
ties: GAILV, ST, FYW, QN, ED, HKR, CM and P 
(W represents the wild-type situation). 
3.5. The suppressed full-length protein is heat labile 
E. coli strain XLlBLUE was transformed with pIV6 
and the 8 amino acid substitution mutants of pIV6 indi- 
cated above. Cells were grown at 28°C and 39°C and 
protein extracts were made and fractionated into low- 
speed supernatants and pellets. The proteins were sep- 
ararated by SDS-PAGE. Fig. 3A displays the polypep- 
tide distribution between the total and soluble fraction 
observed in extracts of cells over-expressing the wild- 
type (pIV6) and three of the mutant gene constructs 
(W-257+Q; W-257+R and W-257+Y) at the restrictive 
temperature of 39°C. The results show that, although the 
wild-type and mutant proteins accumulate to similarly 
high total quantities in these extracts (compare lanes 2, 
4, 6 and 8), there is a marked difference in the solubility 
of these proteins at this restrictive temperature. The wild- 
type and the W-257+Y proteins were found in the solu- 
ble fraction of the protein extracts (lanes 3 and 9) 
whereas most of the W-257+Q and W-257-+R polypep- 
tide chains were recovered in the pellet as aggregated 
species (lanes 5 and 7). All other mutant proteins (see 
above) behaved very similarly to the W-257+Q and W- 
257+R mutants, and were predominantly found in the 
pellet fraction (data not shown). In cells over-expressing 
either the wild-type, or the mutant proteins, the level of 
MCAT proteins that accumulated was lower at the per- 
missive temperature of 28°C than at 39°C. If the cells 
were grown at 28°C however, all 8 mutant proteins were 
found almost exclusively in the soluble fraction. This was 
revealed by both enzyme studies (not shown) and West- 
em blot analyses. Fig. 3B shows a comparison of the 
soluble and total fraction of extracts of cells over-ex- 
pressing the wild-type or the W-257+Q mutant MCAT 
gene either at the restrictive (39°C) or the permissive 
temperature (28°C). This immunoblot not only demon- 
strates that the mutant protein W-257+Q is soluble 
when produced at 28°C (compare lanes 7 and 8), but also 
reveals that the mutant protein is almost exclusively 
found in the low speed pellet fraction when synthesized 
at 39°C (lanes 9 and 10). Recent work [12] has linked 
inclusion body formation to temperature-sensitive d - 
naturation. Schein and Notebom [12] have shown that 
formation of soluble recombinant proteins in E. coli is 
A 123 45 67 89 
B 1 2 3 4 56 7 8 9 10 
Fig. 3. (A) 12% SDS-PAGE of approximately 10 pg (lanes l-5) and 15 
pg (lanes 69) of crude protein extracts of E. coli XLlBlue, grown at 
39”C, harboring various pIV6 recombinant plasmids. Lane 1, XLlBlue 
cells, total protein fraction; lanes 2 and 3, pIV6 total and soluble protein 
fraction; lanes 4 and 5, pIV6(Wz5’Q) total and soluble protein fraction; 
lanes 6 and 7, pIV6(WZ5’R) total and soluble protein fraction; lanes 8 
and 9, pIV6(Wz5’Y) total and soluble protein fraction. (B) Western blot 
analysis of proteins synthesized in E. coli XLlBlue, grown at 28°C and 
39°C expressing pIV6 and PIV~(W~‘~Q). Immunodetection of MCAT- 
related proteins was performed, using anti-E. coli MCAT antibodies [4]. 
Lanes 1 and 2, XLlBlue grown at 39”C, 1 pg of total and soluble 
fraction; lanes 3-6, pIV6, respectively, 0.1 pug of 28°C total protein 
fraction, 28°C soluble protein fraction, 39°C total protein fraction, 
39°C soluble protein fraction; lanes 7-10, pIV6(WZ5’Q), respectively, 
0.1 pg of 28°C total protein fraction, 28°C soluble protein fraction, 
39°C total protein fraction, 39°C soluble protein fraction. Sizes are 
shown in kilodaltons. The position of the MCAT protein is indicated 
by the arrow. 
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favoured by lower growth temperature. A very similar 
situation is found with the mutant MCAT proteins. With 
the exception of the W257+Y mutant, in which the tryp- 
tophan residue is replaced by another aromatic amino 
acid (tyrosine), all other mutants are insoluble at 39°C 
whereas they are clearly soluble when synthesized at low 
temperature. 
tions render the enzyme heat labile. This heat inactiva- 
tion results in aggregation and desolubilization of the 
soluble active enzyme as revealed by the formation of 
inclusion bodies by the temperature shift (not shown). 
A direct correlation between solubility of the protein 
and enzyme activity was also obtained by enzyme stud- 
ies. Table 1 shows the results obtained by analyzing 
MCAT activity of extracts of cells grown at 28°C or 
39°C. The data presented in Table 1 are restricted to 
those obtained for the W257+Y, W257-+Q and 
W257+R mutants. All other mutants gave similar re- 
sults as the W257+Q and W257+R mutants and the 
data have therefore been omitted. The results show that, 
when grown at 28”C, expression of the mutant genes 
results in the synthesis of an active enzyme, at a level 
which is very similar to that of the wild-type gene con- 
struct (column 1). All except the wild-type and the 
W257+Y mutant enzyme, however, are inactivated by 
more than 90% during incubation at 39°C (column 2). 
When grown at 39°C and assayed at 28°C the enzyme 
activity is a mere l-2% of that found with the wild-type 
or the W257+Y construct (column 3). Although this 
result demonstrates that the inactive aggregated state of 
the mutant polypeptides is virtually irreversible, it also 
shows that the mutant polypeptides occasionally fold 
into an active protein when grown at 39°C. Moreover, 
it also implies that the structure of this catalytically ac- 
tive polypeptide is different from that of the bulk of the 
mutant enzyme produced at 28”C, since this residual 
activity found at 39°C is clearly temperature-resistant. 
This finding also explains why introduction of these mu- 
tant genes on high copy number plasmids still renders the 
mutant E. coli strain LA2-89 temperature-resistant (re- 
sults not shown). 
Studies of mutant proteins have revealed that amino 
acid replacements which substantially destabilize the 
protein structure are generally confined to the buried or 
rigid parts of the protein [13]. Tryptophan 257 is, as are 
most tryptophans, probably largely buried. Substitution 
of the tryptophan by a smaller amino acid will introduce 
a cavity, with a corresponding change in the free energy, 
which constitutes one of the reasons for the destabiliza- 
tion of the protein [14]. Also the introduction of any 
polar amino acid into a buried location is energetically 
unfavorable. The disruption of the hydrophobic core of 
the protein by the W257+Q mutation leads to spontane- 
ous thermal unfolding of the protein above a certain 
temperature, i.e. the melting point of the protein has 
been lowered. Once the protein has unfolded, inclusion 
bodies are formed. It is suggested that the temperature- 
sensitive mutations only alter amino acids that have side 
chains of with low crystallographic thermal factors and 
low solvent accessibility in the X-ray crystal structure of 
the wild-type protein [13]. Elucidation of the three-di- 
mensional structure of MCAT will explain the require- 
ment for an aromatic amino acid at this position in the 
polypeptide chain, which assures the temperature stabil- 
ity of the enzyme. 
In summary, the results demonstrate that substitution 
of tryptophan at codon position 257 of the MCAT pol- 
ypeptide chain with a non-aromatic amino acid affects 
its correct folding into an active form at 39°C. Moreo- 
ver, when produced at 28°C all mutant polypeptides 
fold into an active enzyme, but these amino acid substitu- 
Our results demonstrate that the defect in the fubD89 
gene, in combination with the supE44 genotype, is re- 
sponsible for the temperature-sensitive character of 
strain LA2-89. The amber suppressor tRNA, encoded by 
the supE44 allele, must compete with the release factor 
that recognizes its target termination codon. This results 
in only 2-3% of full-length active MCAT protein, com- 
pared to a fabD’ strain, when grown at the permissive 
temperature of 28°C (Table 1). Further heat inactivation 
of the low amount of suppressed protein results in insuf- 
ficient MCAT activity to sustain de novo fatty acid bio- 
synthesis and is responsible for the temperature-sensitive 
growth phenotype of LA2-89. 
Finally, on the bases of our results it can be argued 
that temperature-sensitive mutants may be more effi- 
Table 1 
Malonyl CoA-ACP transacylase relative activities” in E. coli XLlblue transformants and LA2-89 
315 
Extract Cells grown at 28°C Cells grown at 39°C 
28°C assay 39°C assay 28°C assay 39°C assay 
LA2-89 3.5.10-2 f 7.10-3 7.10-4+3.10-4 - _ 
XLlblue 1 fO.l 1.2 + 0.1 1.3 It. 0.1 1.35 + 0.1 
pIV6 433 + 29 547 f 45.6 841 + 43 1013 f 160 
pIV6(Wz5’Q) 420 f 33 18.3 5 5.1 8.1 + 0.8 10.1 f 1.5 
pIV6(Wz5’Y) 385 f 15 581 f 30.5 895 k 65 956 k 185 
pIV6(Wrs7R) 413 + 25.2 30.2 + 3.3 11.3 + 1.9 12.5 f 2.0 
“MCAT activity was measured in the soluble fraction of the protein extracts. MCAT activity of XLlBlue, grown at 28°C and incubated for 30 min 
at 28”C, is set at 1 (1 = 1.1 x 10’ mnol/min/mg). All other MCAT activities, + S.D. (n = 3), are quantified to this value. 
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ciently isolated in nonsense-suppressor strains than in 
wild-type strains of E. coli. 
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